📣 VC round data is live. Check it out!
- Public Comps
- AirSculpt
AirSculpt Valuation Multiples
Discover revenue and EBITDA valuation multiples for AirSculpt and similar public comparables like Community Health Systems, Mater Dei, Auna, M1 Kliniken and more.
AirSculpt Overview
About AirSculpt
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
Founded
2021
HQ

Employees
422
Website
Sectors
Financials (LTM)
EV
$430M
Valuation Multiples
Start free trialAirSculpt Financials
AirSculpt reported last 12-month revenue of $152M and EBITDA of $15M.
In the same LTM period, AirSculpt generated $91M in gross profit, $15M in EBITDA, and had net loss of ($9M).
Revenue (LTM)
AirSculpt P&L
In the most recent fiscal year, AirSculpt reported revenue of $152M and EBITDA of $15M.
AirSculpt is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of 10%, and net margin of (8%).
Financial data powered by Morningstar, Inc.
AirSculpt Stock Performance
AirSculpt has current market cap of $375M, and enterprise value of $430M.
Market Cap Evolution
AirSculpt's stock price is $5.32.
AirSculpt share price decreased by 1.3% in the last 30 days, and increased by 10.2% in the last year.
AirSculpt has an EPS (earnings per share) of $-0.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $430M | $375M | -1.3% | -1.3% | 112.4% | 10.2% | $-0.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAirSculpt Valuation Multiples
AirSculpt trades at 2.8x EV/Revenue multiple, and 28.0x EV/EBITDA.
EV / Revenue (LTM)
AirSculpt Financial Valuation Multiples
As of June 2, 2026, AirSculpt has market cap of $375M and EV of $430M.
AirSculpt has a P/E ratio of (41.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AirSculpt Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


AirSculpt Margins & Growth Rates
AirSculpt grew revenue by 1% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, AirSculpt reported gross margin of 59%, EBITDA margin of 10%, and net margin of (8%).
AirSculpt Margins
AirSculpt Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
AirSculpt Operational KPIs
AirSculpt's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
AirSculpt's Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AirSculpt's Rule of X is 13% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
AirSculpt Competitors
AirSculpt competitors include Community Health Systems, Mater Dei, Auna, M1 Kliniken, Medica Sur, Oncoclínicas, Sikarin, Pihlajalinna, Humana and Chularat Hospital.
Most AirSculpt public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | 0.9x | 5.2x | 7.2x | |||
| 1.5x | 1.5x | 6.0x | 6.7x | |||
| 1.0x | 1.0x | 5.0x | 4.9x | |||
| 0.9x | 1.2x | 7.8x | 8.3x | |||
| 1.0x | 1.0x | 4.5x | 5.0x | |||
| 0.9x | 0.9x | 57.9x | 12.4x | |||
| 2.3x | - | 8.9x | - | |||
| 0.6x | 0.7x | 3.7x | 4.0x | |||
This data is available for Pro users. Sign up to see all AirSculpt competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AirSculpt
| When was AirSculpt founded? | AirSculpt was founded in 2021. |
| Where is AirSculpt headquartered? | AirSculpt is headquartered in United States. |
| How many employees does AirSculpt have? | As of today, AirSculpt has over 422 employees. |
| Who is the CEO of AirSculpt? | AirSculpt's CEO is Yogesh Jashnani. |
| Is AirSculpt publicly listed? | Yes, AirSculpt is a public company listed on Nasdaq. |
| What is the stock symbol of AirSculpt? | AirSculpt trades under AIRS ticker. |
| When did AirSculpt go public? | AirSculpt went public in 2021. |
| Who are competitors of AirSculpt? | AirSculpt main competitors include Community Health Systems, Mater Dei, Auna, M1 Kliniken, Medica Sur, Oncoclínicas, Sikarin, Pihlajalinna, Humana, Chularat Hospital. |
| What is the current market cap of AirSculpt? | AirSculpt's current market cap is $375M. |
| What is the current revenue of AirSculpt? | AirSculpt's last 12 months revenue is $152M. |
| What is the current revenue growth of AirSculpt? | AirSculpt revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of AirSculpt? | Current revenue multiple of AirSculpt is 2.8x. |
| What is the current EBITDA of AirSculpt? | AirSculpt's last 12 months EBITDA is $15M. |
| What is AirSculpt's EBITDA margin? | AirSculpt's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of AirSculpt? | Current EBITDA multiple of AirSculpt is 28.0x. |
| What is the current FCF of AirSculpt? | AirSculpt's last 12 months FCF is $7M. |
| What is AirSculpt's FCF margin? | AirSculpt's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of AirSculpt? | Current FCF multiple of AirSculpt is 65.8x. |
| How many companies AirSculpt has acquired to date? | AirSculpt hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies AirSculpt has invested to date? | AirSculpt hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to AirSculpt
Lists including AirSculpt
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.